JPS6256411A - Beautifying agent - Google Patents

Beautifying agent

Info

Publication number
JPS6256411A
JPS6256411A JP60196827A JP19682785A JPS6256411A JP S6256411 A JPS6256411 A JP S6256411A JP 60196827 A JP60196827 A JP 60196827A JP 19682785 A JP19682785 A JP 19682785A JP S6256411 A JPS6256411 A JP S6256411A
Authority
JP
Japan
Prior art keywords
acid
salt
phosphatidylethanolamine
phase
phosphatidylserine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60196827A
Other languages
Japanese (ja)
Inventor
Yumiko Suzuki
裕美子 鈴木
Akira Akiyasu
秋保 暁
Yoshimori Fujinuma
好守 藤沼
Tomohisa Asahara
智久 浅原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP60196827A priority Critical patent/JPS6256411A/en
Publication of JPS6256411A publication Critical patent/JPS6256411A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Abstract

PURPOSE:A beautifying agent having extremely improved beautifing effects on the skin and high safety, containing one or more compounds selected from sesamol, lecithin, phytic acid, its salt, phosphatidylethanolamine and/or phosphatidylserine, etc. CONSTITUTION:A beautifying agent having beautifying effects on the skin free from side effects unfavorable to the human body, containing 0.005-15wt%, preferably 0.1-10wt% calculated as solid content based on the total amount of composition selected from sesamol, lecithin, phytic acid, its salt, phosphatidylethanolamine, phosphatidylserine, erysorbic acid, its salt, guar gum, nordihydroguaiaretic acid, its salt and propyl gallate as an active ingredient.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は皮膚美白効果が著しく改良された安全性の高い
美白剤に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a highly safe whitening agent with significantly improved skin whitening effects.

[従来の技術] 皮膚のしみなどの発生機序については不明な点もあるが
、一般には、ホルモンの異常や日光からの紫外線の刺激
が原因となってメラニン色素が形成され、これが皮膚内
に異常沈着するものと考えられている。このようなじみ
やあざの治療法にはメラニンの生成を抑制する物質、例
えばビタミンCを大量に投与する方法、グルタチオン等
を注射する方法あるいはL−アスコルビン酸、システィ
ンなどを軟膏、クリーム、ローションなどの形態にして
、局所に塗布するなどの方法がとられている。また欧米
ではハイドロキノン製剤が医薬品として用いられている
[Conventional technology] Although there are some points that are unclear about the mechanism by which skin spots occur, in general, melanin pigments are formed due to hormonal abnormalities or stimulation of ultraviolet rays from sunlight, and this is caused by the formation of melanin within the skin. It is thought that it is abnormally deposited. Treatments for such bruises include the administration of large amounts of substances that suppress melanin production, such as large doses of vitamin C, injections of glutathione, or the use of ointments, creams, and lotions containing L-ascorbic acid, cysteine, etc. Methods such as making it into a form and applying it locally are used. Additionally, hydroquinone preparations are used as pharmaceuticals in Europe and America.

[発明が解決しようとする問題点] L−アスコルビン酸類は安定性の面で問題があり、水分
を含む系では不安定で変色、変臭の原因となり、グルタ
チオン、システィンなどのチオール系化合物はハイドロ
キノンを除いてはその効果の発現がきわめて緩慢である
ため、美白効果が十分ではない。一方、ハイドロキノン
は効果は一応認められているが、感作性があるため一般
には、使用が制限されている。そこでその安全性を向上
させるため高級脂肪酸のモノエステルなどにする試みが
なされているが、これらのエステルは体内の加水分解酵
素によって分解されるため必ずしも安全とは言いがたい
[Problems to be solved by the invention] L-ascorbic acids have problems in terms of stability, and are unstable in systems containing water, causing discoloration and odor. With the exception of , the onset of the effect is extremely slow, so the whitening effect is not sufficient. On the other hand, although hydroquinone has been shown to be effective, its use is generally restricted due to its sensitizing properties. In order to improve its safety, attempts have been made to use monoesters of higher fatty acids, but these esters are not necessarily safe because they are degraded by hydrolytic enzymes in the body.

[問題点を解決するための手段] このような事情に鑑み、本発明者等は、人体に好ましく
ない副作用を有ざずかつ優れた美白剤を開発すべく鋭意
研究を重ねた結果、 (1)セザモール (2)レシチン (3)フィチン酸 (4)フィチン酸の塩 (5)フォスファチジルエタノールアミン(6)フォス
ファチジルセリン (7)エリソルビン酸 (8)エリソルビン酸の塩 (9)グアヤク脂 (10)ノルジヒドログアイアレチック酸(11)ノル
ジヒドログアイアレチック酸の塩(12)没食子酸プロ
ピル がきわめて安全性に優れており、また安定性もよく、十
分に美白効果を発揮することを認め、本発明を完成する
に至った。
[Means for Solving the Problems] In view of the above circumstances, the present inventors have conducted extensive research to develop an excellent skin whitening agent that does not have any unfavorable side effects on the human body, and have found (1) ) Sezamol (2) Lecithin (3) Phytic acid (4) Salt of phytic acid (5) Phosphatidylethanolamine (6) Phosphatidylserine (7) Erythorbic acid (8) Salt of Erythorbic acid (9) Guaiac butter (10) Nordihydroguaiaretic acid (11) Salt of nordihydroguaiaretic acid (12) Propyl gallate is extremely safe and stable, and has a sufficient whitening effect. This was recognized and the present invention was completed.

すなわち、本発明は有効成分として、上記化合物の1種
又は2種以上を含有することを特徴とする美白剤である
That is, the present invention is a whitening agent characterized by containing one or more of the above compounds as active ingredients.

以下本発明の構成について述べる。The configuration of the present invention will be described below.

本発明で使用する化合物は (1)セザモール (2)レシチン (3)フィチン酸 (4)フィチン酸の塩 (5)フォスファチジルエタノールアミン(6)フォス
ファチジルセリン (7)エリソルビン酸 (8)エリソルビン酸の塩 (9)グアヤク脂 (10)ノルジヒドログアイアレチック酸(11)ノル
ジヒドログアイアレチック酸の塩(12)没食子酸プロ
ピル であり、フィチン酸、エリソルビン酸、ノルジヒドログ
アイアレチック酸の塩としてはナトリウム塩やカリウム
塩などがあげられる。これらの化合物を美白剤に配合す
るには一般の脂溶性化合物を配合する方法にならえばよ
い。
The compounds used in the present invention are (1) sezamol (2) lecithin (3) phytic acid (4) salts of phytic acid (5) phosphatidylethanolamine (6) phosphatidylserine (7) erythorbic acid (8) Erythorbic acid salt (9) Guaiac butter (10) Nordihydroguaiaretic acid (11) Nordihydroguaiaretic acid salt (12) Propyl gallate, phytic acid, erythorbic acid, nordihydroguaiaretic acid Salts include sodium salts and potassium salts. These compounds can be blended into a whitening agent by following the method of blending general fat-soluble compounds.

これらの化合物は、1種又は2種以上が適宜選択され配
合される。配合量は、所望の剤型に応じて適宜選択でき
るが、通常組成物全量に対して乾燥固形分として0.0
05〜15重量駕、好ましくは、0.1〜10重量%程
度である。0.005重量%未満では、効果が乏しくな
る傾向があり、逆に15重量%を越えて配合しても効果
の大きな増加は望めない。
One or more of these compounds are appropriately selected and blended. The blending amount can be selected as appropriate depending on the desired dosage form, but it is usually 0.0% as a dry solid content based on the total amount of the composition.
The amount is about 0.05 to 15% by weight, preferably about 0.1 to 10% by weight. If it is less than 0.005% by weight, the effect tends to be poor, and conversely, if it is added in excess of 15% by weight, no significant increase in the effect can be expected.

本発明の美白剤は、乳化型、可溶化型、分散型、皮膜型
、石鹸、軟膏などの形態とすることができる。
The whitening agent of the present invention can be in the form of an emulsion type, a solubilized type, a dispersion type, a film type, a soap, an ointment, and the like.

本発明の美白剤は、上記必須成分に加えて、必要に応じ
て油分、紫外線吸収剤、界面活性剤、防腐剤、保湿剤、
香料、水、アルコール、増粘剤、色剤等を適宜配合する
ことができる。
In addition to the above-mentioned essential ingredients, the skin whitening agent of the present invention may optionally contain oil, ultraviolet absorbers, surfactants, preservatives, humectants,
Flavors, water, alcohol, thickeners, coloring agents, etc. can be added as appropriate.

[本発明の効果] 本発明の美白剤の美白効果を明らかにするために下記の
実験例を示す。
[Effects of the present invention] In order to clarify the whitening effect of the whitening agent of the present invention, the following experimental examples are shown.

(実験例) 表1の処方に基づき常法によってローシコンを製造し美
白効果を測定した。
(Experimental Example) Low Shicon was manufactured by a conventional method based on the formulation shown in Table 1, and its whitening effect was measured.

顔面に、しみ、そばかす等を有する年齢25〜42才の
女性110名をパネルとし、一群10名どし118¥に
わけ、各成分含有ローションを1日1回3ケ月間毎日顔
面に塗布させ、使用後の美白効果を下記の判定基準に基
づいて判定した。
A panel of 110 women between the ages of 25 and 42 who had spots, freckles, etc. on their faces were divided into groups of 10 for 118 yen each, and each lotion containing each ingredient was applied to their faces once a day for 3 months. The whitening effect after use was evaluated based on the following criteria.

(判定基準) 著効:色素沈着が目立たなくなった。(Judgment criteria) Significant results: Pigmentation became less noticeable.

有効二色製沈着がかなり薄くなった。The effective two-color deposit became much thinner.

やや有効二色製沈着がやや薄くなった。Slightly effective two-color deposit became slightly thinner.

無効二色製沈着に変化がなかフた。There was no change in the two-color deposit.

(判定) A:被験者のうち著効および有効の示す割合が80%以
上の場合 B:被験者のうち著効および有効の示す割合が50〜8
0%の場合 C:被験者のうち著効および有効の示す割合が50%以
下の場合 この結果を表1に示した。
(Judgment) A: When the proportion of subjects showing excellent response and efficacy is 80% or more B: The proportion of subjects showing excellent response and efficacy is 50-8
0% case C: The proportion of subjects showing marked response and efficacy is 50% or less The results are shown in Table 1.

表1から明らかなように本発明の美白剤は、美白効果に
優れていることがわる。また皮膚刺激性、感作性は認め
られず、安全性もすぐれていることがわかった。
As is clear from Table 1, the whitening agent of the present invention has an excellent whitening effect. Furthermore, no skin irritation or sensitization was observed, and it was found to be highly safe.

(以下余白) [実施例] 次に実施例をあげて本発明をざらに詳しく説明する。本
発明はこれによって限定されるものではない。配合量は
重量%である。
(The following is a blank space) [Example] Next, the present invention will be explained in detail with reference to Examples. The present invention is not limited thereby. The blending amount is in weight%.

実施例1  バニシングクリーム ステアリン酸               5.0ス
テアリルアルコール           4.0ステ
アリン酸ブチルアルコールエステル  8.0グリセリ
ンモノステアリン酸エステル   2.0レシチン  
               1・0プロピレングリ
コール          10.0グリセリン   
            4.0苛性カリ      
           0,2防腐剤・酸化防止剤  
         適量香料            
       適量イオン交換水          
    残余(製法) イオン交換水にプロピレングリコールと苛性カリを加え
溶解し加熱して700Cに保つ(水相)。他の成分を混
合し加熱融解して70℃に保つ(油相)。水相に油相を
徐々に加え、全部加え終わってからしばらくその温度に
保ち反応をおこさせる。その後ホモミキサーで均一に乳
化し、よくかきまぜなから30℃まで冷却する。
Example 1 Vanishing cream Stearic acid 5.0 Stearyl alcohol 4.0 Stearic acid butyl alcohol ester 8.0 Glycerin monostearate 2.0 Lecithin
1.0 Propylene Glycol 10.0 Glycerin
4.0 caustic potash
0.2 preservatives/antioxidants
Appropriate amount of fragrance
Appropriate amount of ion exchange water
Residue (manufacturing method) Add propylene glycol and caustic potash to ion-exchanged water, dissolve, heat, and maintain at 700C (water phase). Mix other ingredients, heat and melt and keep at 70°C (oil phase). Gradually add the oil phase to the water phase, and after all addition is complete, maintain the temperature for a while to allow the reaction to occur. Then, emulsify the mixture uniformly using a homomixer, stir well, and cool to 30°C.

実施例2 中性クリーム ステアリルアルコール        7.0ステアリ
ン酸            2.0水添ラノリン  
          2,0スクワラン       
      5.02−オクチルドデシルアルコール 
   6.0ポリオキシエチレン(25モル) セチルアルコールエーテル   3.0グリセリンモノ
ステアリン酸エステル 2.0フオスフアチジルセリン
       1.5プロピレングリコール     
   5.0香料               適量
防腐剤・酸化防止剤        適量イオン交換水
           残余(製法) イオン交換水にプロピレングリコールを加え加熱して7
0℃に保つ(水相)。他の成分を混合し加熱融解して7
0℃に保つ(油相)。水相に油相を加え予備乳化をおこ
ない、ホモミキサーで均一に乳化した後、よくかきまぜ
ながら30℃まで冷却する。
Example 2 Neutral Cream Stearyl Alcohol 7.0 Stearic Acid 2.0 Hydrogenated Lanolin
2,0 squalane
5.02-Octyldodecyl alcohol
6.0 Polyoxyethylene (25 moles) Cetyl alcohol ether 3.0 Glycerin monostearate 2.0 Phosphatidylserine 1.5 Propylene glycol
5.0 Fragrance Appropriate amount Preservative/Antioxidant Appropriate amount Ion-exchanged water Remainder (manufacturing method) Add propylene glycol to ion-exchanged water and heat.7
Keep at 0°C (aqueous phase). Mix other ingredients and heat and melt 7.
Keep at 0°C (oil phase). The oil phase is pre-emulsified by adding the oil phase to the water phase, uniformly emulsified using a homomixer, and then cooled to 30°C while stirring well.

実施例3   コールドクリーム 固形パラフィン            5.0密ロウ
              10.0ワセリン   
           15.0流動パラフイン   
        41.0グリセリンモノステアリン酸
エステル 2.0ポリオキシエチレン(20モル) ソルビタンモノラウリン酸エステル 2.0フオスフア
チジルエタノールアミン  1.0石鹸粉末     
          0.1硼砂          
       0.2香料             
    適量防腐剤・酸化防止剤         適
量イオン交換水            残余(製法) イオン交換水に石鹸粉末と硼砂を加え加熱溶解して70
℃に保つ(水相)。他の成分を混合し加熱融解して70
℃に保つ(油相)。水相に油相をかきまぜながら徐々に
加え反応を行う。反応終了後ホモミキサーで均一に乳化
し、乳化後よくかキヨせなから30℃まで冷却する。
Example 3 Cold cream solid paraffin 5.0 Hitsuwa 10.0 Vaseline
15.0 Liquid paraffin
41.0 Glycerin monostearate 2.0 Polyoxyethylene (20 mol) Sorbitan monolaurate 2.0 Phosphatidylethanolamine 1.0 Soap powder
0.1 borax
0.2 fragrance
Appropriate amount of preservative/antioxidant Appropriate amount of ion-exchanged water Residue (manufacturing method) Add soap powder and borax to ion-exchanged water, heat and dissolve.
Keep at °C (aqueous phase). Mix the other ingredients and heat and melt for 70 minutes.
Keep at °C (oil phase). The oil phase is gradually added to the water phase while stirring to carry out the reaction. After the reaction is completed, the mixture is uniformly emulsified using a homomixer, and after the emulsification is cooled to 30°C.

実施例4    乳液 ステアリン酸            2.5セチルア
ルコール          1.5ワセリン    
           5.0流動パラフイン    
       10.0ポリオキシエチレン(10モル
) モノオレイン酸エステル      2.0ポリエチレ
ングリコール1500      3.0トリエタノー
ルアミン         1.0フイチン酸    
          0.5フォスファチジルエタノー
ルアミン   1.0香料             
   適量防腐剤・酸化防止剤         適量
イオン交換水            残余(製法) イオン交換水にポリエチレングリコール1500とトリ
エタノールアミンを加え加熱溶解して70℃に保つ(水
相)。他の成分を混合し加熱融解して70℃に保つ(油
相)。水相に油相を加え予備乳化を行いホモミキサーで
均一に乳化し、乳化後よくかきまぜながら30℃まで冷
却する。
Example 4 Emulsion Stearic acid 2.5 Cetyl alcohol 1.5 Vaseline
5.0 liquid paraffin
10.0 Polyoxyethylene (10 mol) Monooleic acid ester 2.0 Polyethylene glycol 1500 3.0 Triethanolamine 1.0 Phytic acid
0.5 Phosphatidylethanolamine 1.0 Fragrance
Appropriate amount of preservative/antioxidant Appropriate amount of ion-exchanged water Remaining (manufacturing method) Add polyethylene glycol 1500 and triethanolamine to ion-exchanged water, dissolve by heating, and keep at 70°C (water phase). Mix other ingredients, heat and melt and keep at 70°C (oil phase). The oil phase is pre-emulsified by adding the oil phase to the water phase, and the mixture is uniformly emulsified using a homomixer. After emulsification, the mixture is cooled to 30°C while stirring well.

実施例5    乳液 マイクロクリスタリンワックス    1.0密ロウ 
             2.0ラノリン     
          20.0流動パラフイン    
       10.0スクワラン         
     5.0ソルビタンセスキオレイン酸エステル
 4.0ポリオキシエチレン(20モル) ソルビタンモノオレイン酸エステル 1.0フイチン酸
             3.0プロピレングリコー
ル         7.0香料          
      適量防腐剤・酸化防止剤        
 適量イオン交換水            残余(製
法) イオン交換水にプロピレングリコールを加え加熱して7
0℃に保つ(水相)。他の成分を混合し加熱溶解して7
0℃に保つ(油相)。油相をかきまぜながら、これに水
相を徐々に加え、ホモミキサーで均一に乳化する。乳化
後よくかきまぜながら30℃まで冷却する。
Example 5 Emulsion Microcrystalline Wax 1.0 Mitsuwax
2.0 lanolin
20.0 liquid paraffin
10.0 Squalane
5.0 Sorbitan sesquioleate 4.0 Polyoxyethylene (20 mol) Sorbitan monooleate 1.0 Phytic acid 3.0 Propylene glycol 7.0 Fragrance
Appropriate amount of preservatives and antioxidants
Appropriate amount of ion-exchanged water Remaining (manufacturing method) Add propylene glycol to ion-exchanged water and heat.
Keep at 0°C (aqueous phase). Mix other ingredients and heat to dissolve 7.
Keep at 0°C (oil phase). While stirring the oil phase, gradually add the water phase to it and uniformly emulsify with a homomixer. After emulsification, cool to 30°C while stirring well.

実施例6  化粧水 (アルコール相) 95%エチルアルコール         10.0ポ
リオキシエチレン(60モル) 硬化ヒマシ油   2.0 プロピレングリコール        4.0オレイル
アルコール          0.ルシチン    
           2・5(水相) グリセリン            5.0紫外線吸収
剤            適量イオン交換水    
        残余(製法) 水相、アルコール相を調整後可溶化する。
Example 6 Lotion (alcohol phase) 95% ethyl alcohol 10.0 Polyoxyethylene (60 mol) Hydrogenated castor oil 2.0 Propylene glycol 4.0 Oleyl alcohol 0. Lucitin
2.5 (Aqueous phase) Glycerin 5.0 Ultraviolet absorber Appropriate amount of ion-exchanged water
Residue (manufacturing method) Solubilize after adjusting the aqueous phase and alcohol phase.

実施例7  ビールオフ型パック (アルコール相) 95χエタノール            10.0ポ
リオキシエチレン(15モル) オレイルアルコールエーテル     2.0セザモー
ル              5・0防腐剤    
           適量香料          
      適量(水相) ポリビニルアルコール        12.0グリセ
リン             3.0ポリエチレング
リコール1500      1.0イオン交換水  
          残余(製法) 80℃にて水相を調整し、50℃に冷却する。ついで室
温で調整したアルコール相を添加後均−に混合し、放冷
する。
Example 7 Beer-off type pack (alcohol phase) 95χ ethanol 10.0 Polyoxyethylene (15 mol) Oleyl alcohol ether 2.0 Sezamol 5.0 Preservative
Appropriate amount of fragrance
Appropriate amount (aqueous phase) Polyvinyl alcohol 12.0 Glycerin 3.0 Polyethylene glycol 1500 1.0 Ion exchange water
Residue (manufacturing method) Adjust the aqueous phase at 80°C and cool to 50°C. After adding the alcohol phase prepared at room temperature, the mixture is evenly mixed and allowed to cool.

Claims (1)

【特許請求の範囲】 下記化合物から選ばれた1種又は2種以上を含有するこ
とを特徴とする美白剤。 (1)セザモール (2)レシチン (3)フィチン酸 (4)フィチン酸の塩 (5)フォスファチジルエタノールアミン (6)フォスファチジルセリン (7)エリソルビン酸 (8)エリソルビン酸の塩 (9)グアヤク脂 (10)ノルジヒドログアイアレチック酸 (11)ノルジヒドログアイアレチック酸の塩 (12)没食子酸プロピル
[Scope of Claims] A whitening agent characterized by containing one or more selected from the following compounds. (1) Sezamol (2) Lecithin (3) Phytic acid (4) Salt of phytic acid (5) Phosphatidylethanolamine (6) Phosphatidylserine (7) Erythorbic acid (8) Salt of Erythorbic acid (9) Guaiac fat (10) Nordihydroguaiaretic acid (11) Salt of nordihydroguaiaretic acid (12) Propyl gallate
JP60196827A 1985-09-05 1985-09-05 Beautifying agent Pending JPS6256411A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60196827A JPS6256411A (en) 1985-09-05 1985-09-05 Beautifying agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60196827A JPS6256411A (en) 1985-09-05 1985-09-05 Beautifying agent

Publications (1)

Publication Number Publication Date
JPS6256411A true JPS6256411A (en) 1987-03-12

Family

ID=16364321

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60196827A Pending JPS6256411A (en) 1985-09-05 1985-09-05 Beautifying agent

Country Status (1)

Country Link
JP (1) JPS6256411A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5956033A (en) * 1982-09-21 1984-03-31 Matsushita Electric Ind Co Ltd Capacity controlling method of air conditioner
WO1995005156A1 (en) * 1993-08-17 1995-02-23 Schering-Plough Healthcare Products, Inc. Compositions for treating corns, calluses and warts
EP0650720A1 (en) * 1993-10-28 1995-05-03 Sanwa Kagaku Kenkyusho Co., Ltd. Skin care and deodorant compositions
EP0841058A2 (en) * 1996-11-06 1998-05-13 Rhone-Poulenc Rorer Gmbh Phospholipid composition, method of making it and its use
US6278004B1 (en) 1996-11-06 2001-08-21 Aventis Pharma Deutschland Gmbh Stabilized phospholipidic composition
US6368995B1 (en) 1998-09-09 2002-04-09 Maruzen Petrochemical Co., Ltd. Solid catalysts for the polymerization of olefins and process for the production of olefin polymers therewith
JP2005272444A (en) * 2004-02-25 2005-10-06 Kose Corp External preparation for skin
EP1648399A4 (en) * 2003-07-22 2008-03-05 Marta Rendon Method and topical composition for the treatment of hyperpigmented skin

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5956033A (en) * 1982-09-21 1984-03-31 Matsushita Electric Ind Co Ltd Capacity controlling method of air conditioner
WO1995005156A1 (en) * 1993-08-17 1995-02-23 Schering-Plough Healthcare Products, Inc. Compositions for treating corns, calluses and warts
EP0650720A1 (en) * 1993-10-28 1995-05-03 Sanwa Kagaku Kenkyusho Co., Ltd. Skin care and deodorant compositions
EP0841058A2 (en) * 1996-11-06 1998-05-13 Rhone-Poulenc Rorer Gmbh Phospholipid composition, method of making it and its use
EP0841058A3 (en) * 1996-11-06 1999-09-01 Rhone-Poulenc Rorer Gmbh Phospholipid composition, method of making it and its use
US6100413A (en) * 1996-11-06 2000-08-08 Rhone-Poulenc Rorer Gmbh & Co. Method for the stabilization of a phospholipidic composition, method for the production of such a stabilized composition and its use
US6278004B1 (en) 1996-11-06 2001-08-21 Aventis Pharma Deutschland Gmbh Stabilized phospholipidic composition
US6368995B1 (en) 1998-09-09 2002-04-09 Maruzen Petrochemical Co., Ltd. Solid catalysts for the polymerization of olefins and process for the production of olefin polymers therewith
EP1648399A4 (en) * 2003-07-22 2008-03-05 Marta Rendon Method and topical composition for the treatment of hyperpigmented skin
JP2005272444A (en) * 2004-02-25 2005-10-06 Kose Corp External preparation for skin

Similar Documents

Publication Publication Date Title
JPH0899820A (en) Skin external agent
JPH08133952A (en) Skin preparation for external use
JPS6256411A (en) Beautifying agent
JPS6245527A (en) Preventive and remedy for gray hair
KR101460777B1 (en) Cosmetic composition for improving acne
JPH0533683B2 (en)
JP2578394B2 (en) Whitening agent
JPS6360910A (en) Skin drug for external use
JP2676049B2 (en) Skin cosmetics
JPH0745387B2 (en) Hair growth and hair growth promoter
JPH08133948A (en) Skin preparation for external use
JP2663136B2 (en) Whitening cosmetics
JPH08133950A (en) Skin preparation for external use
JPH1192326A (en) Skin preparation for external use
JPS6210006A (en) Skin cosmetic
JPS6322510A (en) External preparation for skin
JPH07149622A (en) Beautifying and whitening preparation
JPS6127367B2 (en)
JPH0692833A (en) Skin external agent
JPH08133949A (en) Skin preparation for external use
JP2522803B2 (en) Cosmetics
JPH08133954A (en) Skin preparation for external use
JPS60116616A (en) Cosmetic
JPH0648929A (en) Skin external preparation
JP3615557B2 (en) Anti-pigmentation agent